Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.
Natasha GuptaTrinity J BivalacquaMisop HanMichael A GorinBen J ChallacombeAlan W PartinMufaddal K MamawalaPublished in: BJU international (2019)
Waiting for RP up to 6 months after diagnosis is not associated with adverse outcomes amongst patients with unfavourable intermediate- to very-high-risk prostate cancer.